Insufficient Mitral Leaflet Remodeling in Relation to Annular Dilation and Risk of Residual Mitral Regurgitation After MitraClip Implantation

Abstract
No abstract available
Funding Information
  • GE Healthcare
  • Bayer
  • Boston Scientific Corporation
  • Medtronic
  • Abbott Vascular
  • Biotronik
  • Leids Universitair Medisch Centrum
  • Edwards Lifesciences
  • European Society of Contraception and Reproductive Health (R-2018-18122, T-2018-17405)